Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator

被引：0
作者：
Jana M. Hoffmeister
N. A. Mark Estes
Ann C. Garlitski
机构：
[1] Tufts Medical Center,The New England Cardiac Arrhythmia Center, The Cardiovascular Center, Department of Medicine
来源：
Journal of Interventional Cardiac Electrophysiology | 2012年 / 35卷
关键词：
Implantable cardioverter defibrillator (ICD); Chronic kidney disease; End stage renal disease; Mortality; Complications;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Implantation of implantable cardioverter defibrillators (ICDs) for primary prevention has been shown to significantly reduce mortality in several randomized controlled trials. However, many of these trials have excluded patients on hemodialysis as well as patients with advanced chronic kidney disease (CKD). Whether the benefits of ICD therapy extend to patients with CKD is not clear. This review will examine the relationship between advancing stage of CKD and risk/benefit of ICD placement. Furthermore, we will review the recent evidence for the rates of complications as CKD advances. The intent is to assist the clinician who is considering the risks and benefits of ICD implantation in patients who have significant competing comorbidities and have not been specifically studied in randomized controlled trials.
引用
收藏
页码：227 / 234
页数：7
相关论文
共 157 条
  • [1] Moss A(1996)Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators The New England Journal of Medicine 335 1933-1940
  • [2] Hall W(2002)Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction The New England Journal of Medicine 346 877-883
  • [3] Cannom D(2004)Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy:Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators The New England Journal of Medicine 350 2151-2158
  • [4] Daubert J(1999)A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators New England Journal of Medicine 341 1882-1890
  • [5] Higgins S(2005)Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure The New England Journal of Medicine 352 225-237
  • [6] Klein H(2003)Prevalence of chronic kidney disease and decreased kidney function in the adult U.S. population American Journal of Kidney Diseases 41 1-12
  • [7] Moss A(2011)Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease American Heart Journal 161 204-209
  • [8] Zareba W(2007)Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death Pacing and Clinical Electrophysiology 30 207-213
  • [9] Hall W(2006)Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease Journal of the American Medical Association 26 1377-1384
  • [10] Klein H(2003)Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia—AMIOVIRT JACC 41 1707-1712
12345678910